From Bulls to BASS: Theragenics Corporation® Extends Prostate Cancer Treatment Awareness Campaign to the Sport of Bass Fishing; Leading Prostate Cancer Treatment Device Provider Signs Champion BASS Angler to Educate Millions of Fans

Business Wire, Jan 17, 2006

ATLANTA -- Following up on the success of its 2005 direct-to-consumer marketing campaign, Theragenics Corporation, a medical device company serving the prostate cancer and surgical markets (NYSE: TGX), announces the extension of its prostate cancer treatment awareness campaign from bull riding to the sport of bass fishing. Professional BASS angler Rick Clunn joins former professional bull rider Owen Washburn to promote the national program's simple message - "know your options for prostate cancer treatment." The campaign launches Sunday, January 22, with the premiere in Sarasota, Fla. of a Theragenics(R) television commercial featuring Clunn.

"The 2005 bull rider campaign was a tremendous success in educating men about proven treatment options," said M. Christine Jacobs, CEO and president of Theragenics. "We experienced significant increases in call volume to our TheraSeed(R) Prostate Cancer Information Center in direct response to awareness efforts in key markets. This year, we hope to build on the success of our direct-to-consumer marketing initiative by reaching more men and their families through a sport that nearly every man has experienced - fishing."

Casting Hope to Men Nationwide

Theragenics, a leading provider of brachytherapy ("seeding") devices for prostate cancer, signed on with ESPN's BASS after realizing its ability to reach consumers nationwide. BASS is the worldwide leader in bass fishing and has more than 535,000 members. In 2005, an estimated 52.6 million people tuned into ESPN2's BASS Saturday programming and nearly 200,000 fans attended BASS tournaments and events.

"BASS has a large and loyal audience, and the popularity of our sport is growing exponentially," said Don Rucks, vice president and general manager of BASS. "We are thrilled to work with another sponsor outside the fishing industry and to help educate our male fans about important health choices, so they can continue to enjoy their quality of life."

TheraSeed, a prostate cancer treatment device manufactured by Theragenics, produces cure rates better than or equal to surgery yet it works with a lower risk of incontinence and impotence. The minimally invasive outpatient procedure offers faster healing times than surgery.

To further support the campaign, Theragenics and ESPN's BASS will team up to promote "Fish with Your Dad Month" in September, coinciding with National Prostate Cancer Awareness Month. Throughout the month, the campaign will focus on reaching fathers and sons. Clunn also will address fans at CITGO Bassmaster Tournament Trail events, including the 11 Elite Series events and three Bassmaster Majors events with information about proven prostate cancer treatment options. Both Clunn and Washburn will make additional guest appearances throughout the year on the Company's behalf to raise consumer and physician awareness.

A 30-second television spot featuring Clunn also will air nationally on ESPN networks throughout the 2006 BASS season, as well as in key local markets to complement Theragenics' national advertising campaign.

Rick Clunn "Hooks" Men as Spokesperson

Clunn has received numerous accolades in the sport of bass fishing. In a decades-long career as a professional angler, he is a four-time CITGO Bassmaster Classic champion, a 30-time CITGO Bassmaster Classic qualifier and last year was voted by fans as greatest angler of all time in ESPN's Greatest Angler Debate. He is one of BASS' all-time money leaders and has been inducted into both the Bass Fishing Hall of Fame and the Freshwater Fishing Hall of Fame.

"In my profession, how I perform during a tournament is dependent on the choices I make leading up to it and how well I've studied my environment," said Clunn. "Men should take the same approach when faced with a disease as serious as prostate cancer in order to make the best treatment choice. I hope that my involvement with this campaign helps more men understand their options."

While Washburn, Theragenics' chief spokesperson for the 2005 campaign, does not plan to compete in Professional Bull Rider (PBR) events in 2006, he leaves behind a collection of great rides and holds the much sought-after title of 1996 PBR World Champion. He will continue to lend his voice to the campaign through personal appearances at special events, including numerous PBR events, in the role as stock contractor.

"The addition of BASS and Rick Clunn to our campaign is going to take it to the next level," said Jacobs. "Theragenics hopes to build upon the momentum of last year's awareness campaign and bring expanded attention to this disease and proven treatment options."

About Theragenics

Theragenics Corporation(R) (NYSE: TGX) is a provider of brachytherapy and surgical products. In Buford, Ga., the Company manufactures and markets its premiere product, the palladium-103 TheraSeed(R) device (www.theraseed.com), and I-Seed, an iodine-125 based device, which are used primarily in the minimally invasive treatment of localized prostate cancer. Theragenics is the world's largest producer of palladium-103 for human use. Through its subsidiary, CP Medical (www.cpmedical.com), based in Portland, Ore., the Company manufactures and distributes wound closure and other medical devices with applications in, among others, the veterinary, brachytherapy, orthopedics, dental, plastic surgery, and cardiology markets. For additional information, call the Company's Investor Relations Department at (800) 998-8479 or visit www.theragenics.com.